Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 8 of 8 citing Arias: A study comparing two protocols of treatment with intravitreal bevacizumab (Avastin).... (0.07 sec) 

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a …

- 80.35.244.216 [PDF] 
ZF Bashshur, ZA Haddad, A Schakal, RF … - American Journal of Ophthalmology, 2007 - Elsevier
Sixty patients (60 eyes) with subfoveal choroidal neovascular membrane (CNV)
attributable to AMD participated in this study at the American University of
Beirut and Hotel Dieu de France Retina Clinics. All lesion types were ...
Cited by 62 - Related articles - All 38 versions

VISUAL OUTCOMES AND GROWTH FACTOR CHANGES OF TWO DOSAGES OF …


TYY LAI, DTL LIU, KP CHAN, FOJ LUK, … - RETINA, 2009 - journals.lww.com
TIMOTHY YY LAI, MD, FRCS,*† DAVID TL LIU, FRCS,*‡ KWOK-PING CHAN, BSC,*
FIONA OJ LUK, MRCS,*† CHI-PUI PANG, DPHIL,* DENNIS SC LAM, MD, FRCOPHTH*†
... Purpose: To evaluate the visual and growth factor changes of two ...
Related articles

Transitions of multifocal electroretinography in patients with age-related macular …


Y Liu, F Wen, J Li, C Zuo, M Li - Documenta Ophthalmologica - Springer
Abstract To evaluate by multifocal electroretino- grams (mfERG) the macular
function before and after combined treatment with photodynamic therapy (PDT) and
intravitreal bevacizumab in eyes suffering from choroidal ...
Related articles - All 2 versions

COMPARISON OF TWO DOSES OF INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT …

- duanessolution.com
L WU, JF AREVALO, MH BERROCAL, M MAIA, … - Retina, 2009 - journals.lww.com
LIHTEH WU, MD,* J. FERNANDO AREVALO, MD,† MARIA H. BERROCAL, MD,‡ MAURICIO
MAIA, MD,§ JOS´E A. ROCA, MD,¶ VIRGILIO MORALES-CANT´ON, MD,** ARTURO A.
ALEZZANDRINI, MD,†† MANUEL J. DÍAZ-LLOPIS, MD‡‡

Anti-VEGF therapy for choroidal neovascularisation previously treated with photodynamic …


S Jyothi, HR Chowdhury, V Chong, S … - Eye, 2009 - nature.com
Twenty-five subjects with predominantly classic CNV, previously treated with PDT
(mean 1.84 PDT sessions) showed reactivation or persistent CNV. The mean
interval between PDT and intravitreal anti-VEGF treatment was 18.32 months ...

Intravitreal Ranibizumab for the Primary Treatment of Choroidal Neovascularization …

- duanessolution.com
TYY LAI, WAIMAN CHAN, DTL LIU, DSC LAM - Retina, 2009 - journals.lww.com
Skip Navigation Links Home > June 2009 - Volume 29 - Issue 6 > Intravitreal
Ranibizumab for the Primary Treatment of Choroi... ... From the *Department of
Ophthalmology and Visual Sciences, Hong Kong Eye Hospital, The Chinese ...
Related articles - All 3 versions

Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of …


S Jyothi, H Chowdhury, M Elagouz, S … - Eye, 2009 - nature.com
The current medical environment demands that quality health care is delivered at
an affordable cost through the use of objective, unbiased clinical data. This
study was undertaken to review the current literature on bevacizumab for ...
Related articles - All 3 versions

Wirksamkeit und Sicherheit der transskleralen Anti-VEGF-Eingabe


PV Vécsei-Marlovits, S Binder, M Stur - Spektrum der Augenheilkunde, 2009 - Springer
Summary. Since the implementation of intravitreal in- jections using inhibitors
of angiogenesis (anti-VEGF), the course of neovascular AMD has improved signifi-
cantly in the last years. Nowadays a reliable stabilisa- tion of visual ...
Related articles


 


Go to Google Home - About Google - About Google Scholar

©2009 Google